Patent · US Active

Preprocalcitonin antigen T epitopes

US8492342B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignees

INSTITUT GUSTAVE ROUSSY · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Faten El Hage · Paris, FR
Vincent Stroobant · Brussels, BE
Pierre Coulie · Brussels, BE
Fathia Mami-Chouaib · Bourg-la-Reine, FR

Key dates

Filing date	Jun 19, 2008
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Nov 24, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to Preprocalcitonin antigen T epitopes, presented by the Major Histocompatibility Complex I (MHC I). These peptides can be used in cancer immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.